BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Amdokitug (Yisaituo) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Amdokitug (Yisaituo)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07261644-1795@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20270114
DTEND;VALUE=DATE:20270115
SUMMARY:Amdokitug (Yisaituo): Phase 3 readout est. (NCT07261644)
DESCRIPTION:Amdokitug (Yisaituo)\, phase 3.\nStudy: A Study to Evaluate the
  Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spond
 ylitis(AS)\nEstimated primary completion: 14 January 2027. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/amdokitug-yisaituo#upcoming-events\n
 Registry record: https://clinicaltrials.gov/study/NCT07261644
URL:https://assetmemo.bio/drug/amdokitug-yisaituo#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07349329-1795@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20280419
DTEND;VALUE=DATE:20280420
SUMMARY:Amdokitug (Yisaituo): Phase 3 readout est. (NCT07349329)
DESCRIPTION:Amdokitug (Yisaituo)\, phase 3.\nStudy: A Study to Evaluate the
  Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondy
 loarthritis (Nr-axSpA)\nEstimated primary completion: 19 April 2028. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/amdokitug-yisaituo#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07349329
URL:https://assetmemo.bio/drug/amdokitug-yisaituo#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
